Oncology News | pharmaphorum

News

Roche pulls cancer drug from Greece in pricing row

Roche has withdrawn a cancer drug from Greece, saying that a series of government-imposed price discounts have made it impossible to market the drug there.

News

KEYTRUDA is a prescription medicine used to treat a kind of skin cancer called melanoma

Keytruda 100mg/4mL Vial and Carton
2015

Merck & Co pulls Keytruda lung cancer filing in Europe

Blow for Merck as Keytruda sales top $1 billion per quarter.

News

AZ licenses rare disease drug to Mereo BioPharma

Mereo Biopharma snaps up drug for AATD.

News

Novartis adds to cancer reach with $3.9 billion acquisition

Novartis backs ambition to be oncology world-leader

News

Celgene under pressure as growth slows

Celgene has revealed disappointing Q3 results and scaled back forecasts for 2020, news which has caused its share price to plunge 18% yesterday.

News

Microsoft, Parexel team up to accelerate drug development

Partnership aims to create tools to improve patient engagement and recruitment.

Roche pulls cancer drug from Greece in pricing row

Merck & Co pulls Keytruda lung cancer filing in Europe

AZ licenses rare disease drug to Mereo BioPharma

Novartis adds to cancer reach with $3.9 billion acquisition

Celgene under pressure as growth slows

Microsoft, Parexel team up to accelerate drug development

Pfizer targets $2.5bn more in cost savings

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks